Trace Metals in Patients with Parkinson’s Disease: A Multi-Center Case-Control Study of Nigerian Patients
DOI:
https://doi.org/10.12974/2309-6179.2013.01.01.4Keywords:
Parkinson’s disease, trace metals, copper, zinc, manganese, iron, neuro-degeneration.Abstract
Background: The roles of environmental factors in the etiologic consideration of Parkinson’s disease (PD) need investigation and clarification, especially in sub-Saharan Africa where genetic mutations are rare. Trace metals toxicity has been associated with pathogenesis of neuro-degeneration including Parkinson’s disease.
Methods: PD patients presenting to three tertiary health facilities located in the south-west, south-south and central Nigeria were studied and compared with age and sex matched controls from the same regions using a protocol containing a structured questionnaire, diagnostic criteria based on the United Kingdom Parkinson’s Disease Society brain bank and atomic absorption spectrophotometry method for analysis of plasma trace metals – copper, zinc, magnesium, manganese and iron.
Findings: Sixty eight consecutive PD patients with a mean age of 65.7±7.29 years and a male preponderance (Male (46)/Female (22) = 2.1:1) had significantly elevated trace metals (namely copper, zinc, magnesium and iron) compared to controls (P<0.001). The means of the trace metals’ levels for the PD and controls were – Copper 51.8 and 14.7µmol/l, Magnesium 3.35 and 2.06mEq/l, Manganese 15.6 and 14.4µmol/l, Iron 78.5 and 17.4µmol/l and Zinc 88.7 and 19.3µmol/l respectively. There was no significant difference in level of manganese between PD patients and controls, though elevated in PD patients residing in the southern part of the country the difference between the PD patients and controls in central region (P=0.29) was insignificant.
Conclusion: The findings of this study suggested a possible role for trace metals toxicity in the pathogenesis of Parkinson’s disease. There is however need for further studies to elucidate the specific roles of these trace metals in the etiology of PD.
References
Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996; 334: 71-76. http://dx.doi.org/10.1056/NEJM199601113340202
Calne DB. Is idiopathic parkinsonism the consequence of an event or a process? Neurology 1994; 44: 5-10. http://dx.doi.org/10.1212/WNL.44.1.5
Chandra RK. Micro-nutrients and immune functions. An overview. Annal New York Acad Sci 1990, 587: 9-16.
Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991; 114: 1953-75. http://dx.doi.org/10.1093/brain/114.4.1953
Engel LS, Checkoway H, Keifer MC, et al. Parkinsonism and occupational exposure to pesticides. Occup Environ Med 2001; 58: 582-89. http://dx.doi.org/10.1136/oem.58.9.582
Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson’s disease maps to chromosome 2p13. Nat Genet 1998; 18: 262-65. http://dx.doi.org/10.1038/ng0398-262
Gasser T. Genetics of Parkinson’s disease. Curr Opin Neurol 2005; 18(4): 363-69. http://dx.doi.org/10.1097/01.wco.0000170951.08924.3d
Gasser T. Update on the genetics of Parkinson’s disease. Mov Disord 2007; Suppl 17: S343-50. http://dx.doi.org/10.1002/mds.21676
Gorell JM, Johnson CC, Rybick BA, et al. Occupational exposure to Manganese, Copper, Lead, Iron and Zinc and the risk of Parkinson’s disease. Neurotoxicity 1999, 20(2/3): 239-49.
Guidotti TL, McNamara J, Moses MS. The interpretation of trace element analysis in body fluids. Indian J Med Res 2008; 128: 524-32.
Hellenbrand W, Seidler A, Robra BP, et al. Smoking and Parkinson’s disease: a case –control study in Germany. Int J Epidemiol 1997; 26: 328-39. http://dx.doi.org/10.1093/ije/26.2.328
Hoehn MM, Yahr MD. Parkinsonism onset, progression and mortality. Neurology 1967; 17(5): 427-42. http://dx.doi.org/10.1212/WNL.17.5.427
Hu H. Poisoning, Drug Overdose and Envenomation. In ‘Harrison’s Principles of Internal Medicine’ 16th ed. (Eds. Kasper DL, AS Fauci, DL Longo, E Braunwauld, SL Hauser, & JL Jameson) Chapter 376, pg. 2580, McGraw-Hill, New York, 2005.
Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996; 47: Suppl 3: S161-S170. http://dx.doi.org/10.1212/WNL.47.6_Suppl_3.161S
Kamel F, Hoppin JA. Association of Pesticide Exposure with neurologic dysfunction and disease. Environ Health Perspect 2004; 112(9): 950-58. http://dx.doi.org/10.1289/ehp.7135
Kaneko JJ. Clinical Biochemistry of Animal. 4th ed. J.J. Kaneko (ed.) Academic Press Inc. New York, 1999: pp. 932.
Kish L. Survey sampling. New York: John Wiley and Sons; 1965.
Lang AE, Lozano AM. Parkinson’s Disease – First of two parts. N Engl J Med 1998; 339: 1044-53. http://dx.doi.org/10.1056/NEJM199810083391506
Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Arch Neurol 1997; 54: 260-64. http://dx.doi.org/10.1001/archneur.1997.00550150024011
Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 1993; 12: 219-28. http://dx.doi.org/10.1159/000110320
Montegomery EB Jr. Heavy metals and the etiology of Parkinson’s disease and other movement disorders. Toxicol 1995, 97: 3-9. http://dx.doi.org/10.1016/0300-483X(94)02962-T
Morens DM, Grandinetti A, Reed D, White LR, Ross GW. Cigarette smoking and protection from Parkinson’s disease: false association or etiologic clue? Neurology 1995; 45: 1041-51. http://dx.doi.org/10.1212/WNL.45.6.1041
Morens DAM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson’s disease: incidence and mortality in a prospective study of middle-aged men. Neurology 1996; 46: 1044-50. http://dx.doi.org/10.1212/WNL.46.4.1044
Okubadejo N, Britton A, Crews C, et al. Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS One 2008; 3(10): e3421. http://dx.doi.org/10.1371/journal.pone.0003421
Okubadejo NU. An analysis of genetic studies of Parkinson’s disease in Africa. Parkinsonism Relat Disord 2008; 14: 177- 82. http://dx.doi.org/10.1016/j.parkreldis.2007.08.006
Okubadejo NU, Ojo OO, Oshinaike O. Clinical profile of parkinsonism and Parkinson’s disease in Lagos, Southwestern Nigeria. BMC Neurology 2010; 10: 1. http://dx.doi.org/10.1186/1471-2377-10-1
Paustenbach D, Galbraith D. Biomonitoring and biomarkers: exposure assessment will never be the same. Environ Health Persp 2006; 114: 1143-49. http://dx.doi.org/10.1289/ehp.8755
Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson’s disease: a metaanalysis. Environ Res 2001; 86: 122-27. http://dx.doi.org/10.1006/enrs.2001.4264
Ritz B, Yu F. Parkinson’s disease mortality and pesticide exposure in Carlifornia 1984-1994. Int J Epidemiol 2000; 292: 323-29. http://dx.doi.org/10.1093/ije/29.2.323
Schonberg BS, Osuntokun BO, Adeuja AOG, et al. Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: Door-to-door community studies. Neurology 1988; 38: 645-46. http://dx.doi.org/10.1212/WNL.38.4.645
Semchuk KM, Love JE, Lee RG. Parkinson’s disease: A test of the multifactorial etiologic hypothesis. Neurology 1993; 43: 1173-80. http://dx.doi.org/10.1212/WNL.43.6.1173
Sloot WN, Van der Sluys-Gelling, Crambsbergen JB. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. J Neurochem 1994, 62: 205-16. http://dx.doi.org/10.1046/j.1471-4159.1994.62010205.x
Taylor KSM, Counsell C. Is it Parkinson’s disease, and if not, what is it? Pract Neurol 2006, 6: 154-65. http://dx.doi.org/10.1136/jnnp.2006.091835
Tzourio C, Rocca WA, Breteler MMB, et al. Smoking and Parkinson’s disease: an age-dependent risk effect? Neurology 1997; 49: 1267-72. http://dx.doi.org/10.1212/WNL.49.5.1267
Vingerhoets FJG, Snow BJ, Tetrud JW, Langston JW, Schulzer M, Calne DB. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 1994; 36: 765-70. http://dx.doi.org/10.1002/ana.410360513
Willis AW, Evanoff BA, Lian M, et al. Metal emissions and urban incident Parkinson Disease: A community Health Study of Medicare Beneficiaries by using Geographic Information Systems. Am J Epidemiol 2010; 172(12): 1357- 63. http://dx.doi.org/10.1093/aje/kwq303
Zhang Z-X, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993; 12: 195-208. http://dx.doi.org/10.1159/000110318
Zotta P, Luchini R, Van Rensburg SJ, Taylor A. The role of metals in neurodegenerative processes: Al, Mn and Zn. Brain Res Bull 2003, 62(1): 15-28. http://dx.doi.org/10.1016/S0361-9230(03)00182-5